Home brain stimulation improves walking
- Trial ID
- NCT07518290
- Official Title
- Remotely Supervised Home-based Transcranial Temporal Interference Stimulation on Motor Symptoms in Parkinson's Disease: Protocol For a Double Blind Randomized Controlled Trial
- Goal
- Home brain stimulation improves walking
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Shanghai University of Sport
- Study Type
- INTERVENTIONAL
- Enrollment
- 68 participants
- Conditions
- PARKINSON DISEASE (Disorder), Motor Symptoms
- Interventions
- Home-based Transcranial Temporal Interference Stimulation (HB-TIS)
Plain-Language Summary
They're testing whether remotely supervised, home-based temporal interference brain stimulation can reduce motor symptoms like slowness, stiffness, and gait problems in people with mild-to-moderate Parkinson's. The treatment uses two high-frequency electrical currents applied through scalp electrodes that overlap inside the brain to produce a low-frequency stimulation that reaches deeper motor circuits without surgery, and sessions are done at home under remote supervision while participants keep their anti-parkinsonian medications stable. Enrollment is for people age 40 to 80 with Parkinson's at Hoehn and Yahr stages 1.5 to 3 who can walk unaided for at least 2 minutes, excluding those with DBS or metal implants, significant cognitive impairment (MoCA <21), other major neurological or orthopedic problems, or serious psychiatric illness.
Locations
- Shanghai University of Sport, Shanghai, Shanghai Municipality, China
- Shanghai University of Sport, Shanghai, Shanghai Municipality, China
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Home-based Transcranial Temporal Interference Stimulation (HB-TIS). They're testing whether remotely supervised, home-based temporal interference brain stimulation can reduce motor symptoms like slowness, stiffness, and gait problems in people with mild-to-moderate Parkinson's. The treatment uses two high-frequency electrical currents applied through scalp electrodes that overlap inside the brain to produce a low-frequency stimulation that reaches deeper motor circuits without surgery, and sessions are done at home under remote supervision while participants keep their anti-parkinsonian medications stable. Enrollment is for people age 40 to 80 with Parkinson's at Hoehn and Yahr stages 1.5 to 3 who can walk unaided for at least 2 minutes, excluding those with DBS or metal implants, significant cognitive impairment (MoCA <21), other major neurological or orthopedic problems, or serious psychiatric illness.
- Who can participate?
- Participants must be between 40 Years and 80 Years.
- Where is this trial located?
- This trial is recruiting at 2 locations.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 10 months.